AIGH Capital Management LLC In its 13F for Q3 2024 (holdings as of September 30, 2024, filed November 13, 2024), AIGH Capital Management LLC reported 37 stock positions worth $213.6 million . Its top holding was Personalis (PSNL) at 10.1% of the portfolio, followed by Scpharmaceuticals (SCPH, 8.8% ) and Arq (ARQ, 7.7% ). Compared with Q2 2024, it opened 9 new positions, sold out of 7, added to 6 and reduced 9. The biggest buy was a new position in Personalis (PSNL) and the biggest sale an exit from Silicon Motion Technol-ADR (SIMO).
Location BALTIMORE, MD
CIK 0001835943
Portfolio Value $213.6M (Q3 2024) Holdings 37 stocks · $213.6M Holdings quarter Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024
Stock % Of Portfolio ▼ Shares Held Total Value Change vs Q2 2024 PSNL Personalis Inc. 3,999,064 $21.5M New SCPH Scpharmaceuticals Inc. 4,124,367 $18.8M Add +17.7% ARQ Arq Inc. 2,817,078 $16.5M Add +31.5% DCTH Delcath Systems Inc. 1,782,490 $16.1M Reduce -25.7% APPS Digital Turbine Inc. 4,490,140 $13.8M New MYO Myomo Inc. 2,778,848 $11.1M Reduce -4.8% GLW Corning Inc. 225,000 $10.2M New BDSX Biodesix Inc. 5,679,812 $10.1M Reduce -1.7% ELUT Elutia Inc. 2,510,442 $9.6M Add +47.9% CLRB Cellectar Biosciences Inc. 3,197,394 $6.8M Add +5.3% TARS Tarsus Pharmaceuticals Inc. 204,413 $6.7M New TELA Tela Bio Inc. 2,469,373 $6.2M Add +49.1% XERS Xeris Biopharma Holdings Inc. 2,185,654 $6.2M New BKTI BK Technologies Corp. 282,772 $6.2M No change IPWR Ideal Power Inc. 700,000 $5.7M No change ELVA Electrovaya Inc. 2,447,626 $5.7M Reduce -5.0% LPTH Lightpath Technologies Inc. Class A 3,723,932 $5.1M No change THTX Theratechnologies Inc. 3,725,204 $4.6M No change EGRX Eagle Pharmaceuticals Inc. 1,211,509 $4.5M No change COYA Coya Therapeutics Inc. 649,427 $4.2M No change IDN Intellicheck Inc. 1,767,732 $3.8M No change PYPD Polypid Ltd. 679,668 $2.4M Add +41.8% MRAM Everspin Technologies Inc. 373,888 $2.2M New MX Magnachip Semiconductor Corp. 450,000 $2.1M New ACASTI PHARMA INC 641,083 $1.9M No change FKWL Franklin Wireless Corp. 390,000 $1.8M No change IMMX Immix Biopharma Inc. 1,123,663 $1.7M Reduce -20.1% APRE Aprea Therapeutics Inc. 539,300 $1.5M No change XAIR Beyond Air Inc. 3,602,991 $1.4M Reduce -1.0% KPRX Kiora Pharmaceuticals Inc. 255,555 $935K Reduce 0.0% BIOMX INC 865,400 $883K New CNSY Plus Therapeutics Inc. 560,905 $819K Reduce -1.4% BFRI Biofrontera Inc. 501,434 $667K No change SMTK Smartkem Inc. 134,687 $574K No change INAB IN8BIO Inc. 1,674,638 $452K Reduce -21.3% MCHX Marchex Inc. Class B 198,100 $370K New EVOK Evoke Pharma Inc. 70,546 $339K No change
Options reported separately and not counted above: XBI puts ($110.4M), GLW calls ($30.5M).
Other holdings (1): bonds, preferreds, convertibles and warrants · $45K (not counted above) Security Class Shares / Principal Value Change SVREW Saverone 2014 Ltd. -CW27 *W EXP 06/02/202 568,194 $45K No change
Total filed on the 13F, all lines: $213.6M.
Portfolio Sells Q2 2024 → Q3 2024 Portfolio Sells quarter Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024
Stock Change vs Q2 2024 % Of Portfolio Change To Portfolio ▲ SIMO Silicon Motion Technol-ADR Sold out 0.00% −10.87 INFN Infinera Corp. Sold out 0.00% −10.01 RCAT Red Cat Holdings Inc. Sold out 0.00% −2.76 PROF Profound Medical Corp. Sold out 0.00% −2.65 DCTH Delcath Systems Inc. Reduce -25.7% 7.54% −2.27 INAB IN8BIO Inc. Reduce -21.3% 0.21% −0.67 IMMX Immix Biopharma Inc. Reduce -20.1% 0.78% −0.58 ELVA Electrovaya Inc. Reduce -5.0% 2.68% −0.56 ZVRA Zevra Therapeutics Inc. Sold out 0.00% −0.43 XAIR Beyond Air Inc. Reduce -1.0% 0.65% −0.31 CGTX Cognition Therapeutics Inc. Sold out 0.00% −0.24 VCNX Vaccinex Inc. Sold out 0.00% −0.21 KPRX Kiora Pharmaceuticals Inc. Reduce 0.0% 0.44% −0.09 CNSY Plus Therapeutics Inc. Reduce -1.4% 0.38% −0.02 BDSX Biodesix Inc. Reduce -1.7% 4.73% +0.42 MYO Myomo Inc. Reduce -4.8% 5.22% +0.65
Portfolio Buys Q2 2024 → Q3 2024 Portfolio Buys quarter Q2 2026 Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024
Stock Change vs Q2 2024 % Of Portfolio Change To Portfolio ▼ PSNL Personalis Inc. New 10.07% +10.07 APPS Digital Turbine Inc. New 6.45% +6.45 GLW Corning Inc. New 4.76% +4.76 TARS Tarsus Pharmaceuticals Inc. New 3.15% +3.15 XERS Xeris Biopharma Holdings Inc. New 2.92% +2.92 ARQ Arq Inc. Add +31.5% 7.74% +1.40 SCPH Scpharmaceuticals Inc. Add +17.7% 8.81% +1.36 MRAM Everspin Technologies Inc. New 1.03% +1.03 MX Magnachip Semiconductor Corp. New 0.98% +0.98 BIOMX INC New 0.41% +0.41 ELUT Elutia Inc. Add +47.9% 4.48% +0.37 MCHX Marchex Inc. Class B New 0.17% +0.17 PYPD Polypid Ltd. Add +41.8% 1.11% +0.11 CLRB Cellectar Biosciences Inc. Add +5.3% 3.20% −0.15 TELA Tela Bio Inc. Add +49.1% 2.92% −0.88
Options Activity Q2 2024 → Q3 2024 Security Type Change vs Q2 2024 Underlying Shares Value ▼ XBI SS SPDR S&P Biotech ETF put Reduce -50.0% 500,000 $110.4M GLW Corning Inc. call New 675,000 $30.5M WDC Western Digital Corp. call Sold out 300,000 $22.7Mbefore exit ZVRA Zevra Therapeutics Inc. call Sold out 137,600 $674Kbefore exit
Calls and puts are listed by the shares they cover; their value is not part of the stock holdings above.
All Filings Quarter Positions 13F Reported Value Top Holdings Q2 2026 42 $1.1B SNDK, MXL, INTC, APPS, SIMO Q1 2026 40 $488.3M SNDK, TYGO, SIMO, ZBRA, LASR Q4 2025 31 $338.3M SNDK, CSTL, PSNL, LASR, DAWN Q3 2025 34 $285.6M SNDK, PSNL, HUCK, ARQ, MXL Q2 2025 34 $213.1M PSNL, HUCK, SCPH, ARQ, VPG Q1 2025 38 $192.7M VSTM, MYO, PSNL, ARQ, SCPH Q4 2024 36 $265.7M PSNL, MYO, ARQ, DCTH, MRVL Q3 2024 37 $213.6M PSNL, SCPH, ARQ, DCTH, APPS Q2 2024 35 $204.9M SIMO, INFN, DCTH, SCPH, ARQ Q1 2024 39 $207.3M SCPH, OUST, ELVA, CLRB, DCTH